Latest news
Loading news…
Lumos Pharma is a biopharmaceutical company that develops a novel treatment for the rare disease Creatine Transporter Deficiency.
Lumos Pharma was acquired by Double Point Ventures in 2024 for $38M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
45
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Austin, Texas, United States
Acquisitions by Lumos Pharma
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Lumos Pharma
President , CEO & Chairman
Scientific Advisory Board
VP, Clinical Operations
Scientific Advisory Board
Scientific Advisory Board
Board of Directors
Chief Medical Officer
45
professional contacts at Lumos Pharma
Contact execs at Lumos Pharma →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Lumos Pharma
Loading news…
FAQs about Lumos Pharma
People who checked this page also checked these
Sectors Lumos Pharma invests & acquires in
Browse the full Acquirezy directory.